These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28398342)

  • 1. Two subgroups of antipsychotic-naive, first-episode schizophrenia patients identified with a Gaussian mixture model on cognition and electrophysiology.
    Bak N; Ebdrup BH; Oranje B; Fagerlund B; Jensen MH; Düring SW; Nielsen MØ; Glenthøj BY; Hansen LK
    Transl Psychiatry; 2017 Apr; 7(4):e1087. PubMed ID: 28398342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients.
    Ebdrup BH; Axelsen MC; Bak N; Fagerlund B; Oranje B; Raghava JM; Nielsen MØ; Rostrup E; Hansen LK; Glenthøj BY
    Psychol Med; 2019 Dec; 49(16):2754-2763. PubMed ID: 30560750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients.
    Düring S; Glenthøj BY; Oranje B
    Int J Neuropsychopharmacol; 2015 Oct; 19(3):pyv109. PubMed ID: 26453696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?
    Goldberg TE; Goldman RS; Burdick KE; Malhotra AK; Lencz T; Patel RC; Woerner MG; Schooler NR; Kane JM; Robinson DG
    Arch Gen Psychiatry; 2007 Oct; 64(10):1115-22. PubMed ID: 17909123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-episode schizophrenia patients neuropsychologically within the normal limits: evidence of deterioration in speed of processing.
    González-Blanch C; Rodríguez-Sánchez JM; Pérez-Iglesias R; Pardo-García G; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2010 Jun; 119(1-3):18-26. PubMed ID: 20335007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state.
    Higuchi Y; Sumiyoshi T; Seo T; Miyanishi T; Kawasaki Y; Suzuki M
    PLoS One; 2013; 8(1):e54080. PubMed ID: 23349791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, EEG mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine.
    Saletu B; Küfferle B; Grünberger J; Földes P; Topitz A; Anderer P
    Neuropsychobiology; 1994; 29(3):125-35. PubMed ID: 7912819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
    Bilder RM; Goldman RS; Robinson D; Reiter G; Bell L; Bates JA; Pappadopulos E; Willson DF; Alvir JM; Woerner MG; Geisler S; Kane JM; Lieberman JA
    Am J Psychiatry; 2000 Apr; 157(4):549-59. PubMed ID: 10739413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustering of antipsychotic-naïve patients with schizophrenia based on functional connectivity from resting-state electroencephalography.
    Ambrosen KS; Fredriksson F; Anhøj S; Bak N; van Dellen E; Dominicus L; Lemvigh CK; Sørensen ME; Nielsen MØ; Bojesen KB; Fagerlund B; Glenthøj BY; Oranje B; Hansen LK; Ebdrup BH
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1785-1796. PubMed ID: 36729135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.
    Düring S; Glenthøj BY; Andersen GS; Oranje B
    Neuropsychopharmacology; 2014 Dec; 39(13):3000-8. PubMed ID: 24954063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in semantic information processing in schizophrenics.
    Volz HP; Mackert A; Frick K; Bücker U
    Pharmacopsychiatry; 1994 Mar; 27(2):59-62. PubMed ID: 7913235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of verbal memory and learning in antipsychotic-naïve patients with first-episode schizophrenia.
    Hill SK; Beers SR; Kmiec JA; Keshavan MS; Sweeney JA
    Schizophr Res; 2004 Jun; 68(2-3):127-36. PubMed ID: 15099597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological dysfunction in antipsychotic-naive first-episode unipolar psychotic depression.
    Hill SK; Keshavan MS; Thase ME; Sweeney JA
    Am J Psychiatry; 2004 Jun; 161(6):996-1003. PubMed ID: 15169687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls.
    Ahn YM; Lee KY; Kim CE; Kim JJ; Kang DY; Jun TY; Choi JS; Chung IW; Kim SH; Hwang SS; Kim YS
    J Clin Psychopharmacol; 2009 Apr; 29(2):117-23. PubMed ID: 19512972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
    Polgár P
    Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia.
    Berman I; Viegner B; Merson A; Allan E; Pappas D; Green AI
    Schizophr Res; 1997 May; 25(1):1-10. PubMed ID: 9176922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.